Rivaroxaban Shown to Cut Risk of Cardiovascular EventsRivaroxaban (Xarelto, Janssen/ Bayer) has been found to significantly reduce the risk of strokes and heart attacks in patients with artery disease.
In this issue
Balancing Act: Dealing with Stress in the Pharmacy September 12, 2017By Jill SederstromIt's no news that pharmacists are stressed, but how is it affecting job performance—and how do pharmacists cope? PBMs Look to the Future September 12, 2017By Mari EdlinPBMs are evolving, but what will they be evolving into and will they be more transparent? Neratinib for Early Stage Breast CancerNeratinib (Nerlynx) is an extended adjuvant treatment for patients with early stage HER2 positive breast cancer who are receiving trastuzumab therapy. Pharmacists Can Help Reduce Repeat MIs September 12, 2017By Beth Longware DuffNonadherence to treatment plans is a contributing factor in for many second myocardial infarctions. Are You Keeping Your Patients' Digital Info Safe? September 12, 2017By Jill SederstromRansomware and cybersecurity threats expose patients to risks. The Underappreciated Risks of Hospital IV CompoundingTechnology can help reduce error rates in IV compounding. Limits on Opioid Prescriptions Gain Popularity September 12, 2017By Valerie DeBenedetteOpioid limits are gaining popularity, but do they actually work? Express Scripts’ New Formulary Favors Biosimilars, Cuts Opioids September 12, 2017By Christine BlankCheck out the latest changes to the Express Scripts formulary “Check Your Meds Day” Is Coming September 12, 2017By Nicholas HammHow one day could help your patients manage their meds. Clinical Challenge: Treating Nasal Congestion with Concomitant HypertensionIn Clinical Challenge, we give you one case and two different expert opinions. You decide the best approach.